Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?

C Opasich1, A Russo, R Mingrone

  • 1S. Maugeri Foundation, Institute of Care and Scientific Research, Cardiology Division, Medical Center of Pavia, 27100, Pavia, Italy. copasich@fsm.it

European Journal of Heart Failure
|April 1, 2000
PubMed
Summary

This review covers updated guidelines for intravenous inotropic agents in refractory heart failure management. It compares their effects on cardiac and peripheral systems and discusses clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma.

Cancer·1996
Same author

Intake of macronutrients and risk of breast cancer.

Lancet (London, England)·1996
Same author

Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress.

Metabolism: clinical and experimental·1996
Same author

Regional wall motion analysis by dobutamine stess echocardiography to distinguish between ischemic and nonischemic dilated cardiomyopathy.

American heart journal·1996
Same author

Pleomorphic adenoma and adenoid-cystic carcinoma of salivary glands: immunohistochemical assessment of proliferative activity in comparison with flow-cytometric study.

Cell proliferation·1996
Same author

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.

British journal of cancer·1996

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Refractory heart failure management requires preventing organ damage from poor oxygen delivery.
  • Key goals include improving hemodynamics and maximizing cardiac output.
  • Maintaining mildly elevated ventricular filling pressures is crucial.

Purpose of the Study:

  • To review updated indications for intravenous inotropic agents.
  • To compare the cardiac and peripheral effects of these agents.
  • To review clinical implications of their use, alone or in combination.

Main Methods:

  • Literature review of updated guidelines and clinical studies.
  • Comparative analysis of intravenous inotropic agents.
  • Synthesis of clinical data on efficacy and safety.

Related Experiment Videos

Main Results:

  • Specific indications for intravenous inotropic agents in refractory heart failure are detailed.
  • Comparative analysis highlights distinct cardiac and peripheral effects.
  • Clinical implications cover monotherapy and combination strategies.

Conclusions:

  • Intravenous inotropic agents play a vital role in managing refractory heart failure.
  • Understanding their specific effects guides optimal therapeutic strategies.
  • Evidence supports their use in selected patients to improve outcomes.